Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIGID: Intravenous Glyceryl Trinitrate in Acute Ischemic Stroke
ChiCTR2100044801Phase 4Recruiting
- Sponsor
- Beijing Luhe Hospital
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nitroglycerin in ischemic stroke (2 arms), sponsored by Beijing Luhe Hospital. Primary endpoint: 90-day modified Rankin Scale (mRS). Started Apr 2021; status: recruiting.
02
Drugs
nitroglycerin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2100044801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044801.